Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
4.950
-0.120 (-2.37%)
At close: Dec 20, 2024, 4:00 PM
4.990
+0.040 (0.81%)
After-hours: Dec 20, 2024, 5:47 PM EST

Sagimet Biosciences Revenue

In the year 2023, Sagimet Biosciences had annual revenue of $2.00M.

Revenue (ttm)
$2.00M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
10
Market Cap
159.37M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.00M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nanobiotix 45.22M
Cellectis 36.04M
scPharmaceuticals 30.28M
Caribou Biosciences 11.48M
TScan Therapeutics 9.36M
Checkpoint Therapeutics 47.00K
Revenue Rankings